MODULAR MEDICAL INC
MODDNASDAQ🏆 #4684 by market capEarnings Nov 12US Equity
$1.88▲ $0.22 (+13.25%)
Pre-market · at closeTrack MODD
Get earnings, price moves & breaking news on Telegram
24h▲ 13.3%
7d▼ 2.3%
14d▼ 15.7%
30d▼ 9.4%
ytd▼ 82.4%
1y▼ 88.0%
🏦Market Cap
$18M
Small Cap
📈Revenue Growth (YoY)
—
📊Gross Margin
—
💵FCF Margin
—
⚖️P/S Ratio
—
Otter Score
—
Insufficient data
Trading Snapshot
- Day Range
- $1.88 – $1.88
- 52-Week Range
- $1.60 – $18.67
- Volume (shares)
- 12,672
- Avg Volume (shares)
- —
- Shares Outstanding
- 9.5M
- Next Earnings
- 2026-11-12
Fundamentals Snapshot
- Annual Revenue
- —
- Last Q Revenue
- —
- P/E Ratio
- —
- P/S Ratio
- —
- EPS (TTM)
- $-10.69
- Dividend Yield
- —
- Dilution (1yr)
- +148.1%
MODULAR MEDICAL INC
MODDFinancial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$0▲ +0.0% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
−$28M▲ +44.7% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
−$28M▲ +52.0% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
5.5M▲ +148.1% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$4M▲ +$1M YoY
StockOtter · stockotter.spaceAbout MODULAR MEDICAL INC
Modular Medical, Inc. is an emerging medical technology company primarily focused on the creation, refinement, and market introduction of insulin pumps. The firm aims to leverage advanced technology to increase the adoption and use of these devices among individuals with diabetes. Its main corporate offices are situated in San Diego, California.
🦦
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Insufficient data for all five components.
💧Dilution★★★★★
Overall Score
Insufficient data
—/100
Analyst Ratings
ⓘConsensus
Buy
7 analysts
Strong Buy2
Buy4
Hold1
Sell0
Strong Sell0
Ratings as of May 2025
Latest News & Updates
News unavailable.